What this study is
The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice.
Data will be collected both retrospectively and prospectively.
What's being tested
- Gelsoft Plus Vascular Graft
Intervention · DEVICE
Gelatin coated, knitted vascular prosthesis implanted to act as a conduit for channeling blood during repair of damaged or diseased vessels.
- Vascular Bypass Graft
Intervention · DEVICE
Gelatin coated, knitted vascular prosthesis implanted to act as an extra-anatomical bypass for channeling blood during repair of damaged or diseased vessels.
- Cardiovascular Patch
Intervention · DEVICE
Cardiovascular knitted polyester patches are frequently used to treat the carotid or femoral arteries to prevent stroke and repair damage to vessels.
- Gelweave Vascular Graft
Intervention · DEVICE
The Gelweave woven polyester vascular graft allows replacement of large sections of arteries and, following anastomosis to the native blood vessel, provides a stable conduit for blood flow.
- Gelweave Valsalva Vascular Graft
Intervention · DEVICE
This woven polyester graft is designed to match the aortic root anatomy and is implanted to repair or replace a portion of the aorta in case of an aneurysm, dissection or coarctation at the level of the thoracic aorta.
Study details
- Official title
- A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
- Sponsor
- Vascutek Ltd.
- Conditions
- Aneurysm · Dissection · Aortic Root Aneurysm · Aortic Root Dissection · Carotid Artery Injuries · Aortic Arch · Bypass Extremity Graft · Occlusive Vascular Disease · Aortic Diseases
- Enrolling
- 2,000 people
- Starts
- 2021-02-17
- Est. completion
- 2037-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patient meets the minimum age as per local regulations at time of consent
- Patient requires treatment with study device(s) according to the IFU(s)
- Patient is willing and able to comply with all SOC procedures and study visits
- Patient or their legally authorised representative (LAR) has given written informed consent to participate in study, including consent to collect data retrospectively; For prospective emergency patients, retrospective consent is permissible; For retrospective patients who are deceased at time of enrollment, local EC regulations relating to consent process should be followed.
- Patient has a minimum of 1 year post-operative follow-up data available, or complete data to death.
- Patient implant date is no more than 5 years prior to study start date.
You can't join if
- Patient is unable or unwilling to comply with the SOC procedures or follow-up regime; Patient is contraindicated per the device IFU; Patient has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving this treatment and the procedures and evaluations pre- and post-procedure
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (30)
26 openUniversity of Colorado Anschutz
Aurora, Colorado, United States
- Brett Reece · Contact
- Brett Reece · Principal investigator
RecruitingUniversity of South Florida - Tampa General
Tampa, Florida, United States
- Thanh Tran · Contacttqtran@usf.edu
- Murray Shames · Principal investigator
RecruitingIndiana University Health
Indianapolis, Indiana, United States
- Joel Corvera, MD · Contactjcorvera@iuhealth.org
- Joel Corvera · Principal investigator
RecruitingDuke University
Durham, North Carolina, United States
- Chad Hughes · Contactgchad.hughes@duke.edu
- Chad Hughes · Principal investigator
RecruitingEast Carolina University
Greenville, North Carolina, United States
- Eddie Hill · ContactHille19@ecu.edu
- Benjamin Degner · Principal investigator
RecruitingUniversity Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Terence Semenec · Contactterence.semenec@UHhospitals.org
- Jae Cho · Principal investigator
RecruitingOhio State University
Columbus, Ohio, United States
- Kristine Orion · Contact
- Kristine Orion · Principal investigator
RecruitingLehigh Valley Hospital
Allentown, Pennsylvania, United States
- James Wu · ContactJames.Wu@lvhn.org
- James Wu · Principal investigator
RecruitingUniversity of Pennsylvania
Philadelphia, Pennsylvania, United States
- Eric Suchanec · ContactEric.Suchanec@Pennmedicine.upenn.edu
- Nimesh Desai · Principal investigator
RecruitingVirginia Commonwealth University
Richmond, Virginia, United States
- Daniel Newton, MD · Contactdaniel.newton@vcuhealth.org
- Daniel Newton · Principal investigator
Recruiting
20 sites outside the US
UZ Gent
Ghent, Belgium
- Nathalie Moreels · Contactnathalie.moreels@uzgent.be
- Nathalie Moreels · Principal investigator
RecruitingAZ Groeninge Kortrijk
Kortrijk, Belgium
- Philip Lerut · Contactphilip.lerut@azgroeninge.be
- Philip Lerut · Principal investigator
RecruitingUZ Leuven
Leuven, Belgium
- Peter Verbrugghe · Contactpeter.verbrugghe@uzleuven.be
- Peter Verbrugghe · Principal investigator
RecruitingCHU Clermont Ferrand
Clermont-Ferrand, France
- Valerie Batel · Contactvbatel@chu-clermontferrand.fr
- Thaveau · Principal investigator
RecruitingCHU de Dijon
Dijon, France
- Olivier Bouchot · Contact
- Olivier Bouchot · Principal investigator
RecruitingCHU de Lille
Lille, France
- Mohamad Koussa · Contact
- Mohamad Koussa · Principal investigator
RecruitingHôpital Nord Marseille
Marseille, France
- Yves Alimi · Contact
- Yves Alimi · Principal investigator
RecruitingHôpitaux Universitaires de Strasbourg - Hôpital Civil
Strasbourg, France
- Nabil Chakfe · Contact
- Nabil Chakfe · Principal investigator
RecruitingCHU de Toulouse - Hôpital Rangueil
Toulouse, France
- Xavier Chaufour · Contact
- Xavier Chaufour · Principal investigator
RecruitingCharité Berlin
Berlin, Germany
- Irene Hinterseher · Contactgefaesschirurgie@charite.de
- Irene Hinterseher · Principal investigator
RecruitingUniklinik Bonn
Bonn, Germany
- Marwan Hamiko · Contactmarwan.hamiko@ukbonn.de
- Marwan Hamiko · Principal investigator
RecruitingUNIVERSITÄTSKLINIKUM FREIBURG/Bad Krozingen
Freiburg im Breisgau, Germany
- Gabriele Lechner · Contactgabriele.lechner@uniklinik-freiburg.de
- Martin Czerny · Principal investigator
RecruitingUKE Hamburg
Hamburg, Germany
- Sebastian Debus · Contacts.debus@uke.de
- Sebastian Debus · Principal investigator
RecruitingHeart Center Leipzig
Leipzig, Germany
- Michael Borger · Contact
- Michael Borger · Principal investigator
RecruitingUniversitätsmedizin Mainz (University Hospital Mainz)
Mainz, Germany
- Hazem El Beyrouti · Contact
- Hazem El Beyrouti · Principal investigator
RecruitingLudwig-Maximilian Universität (LMU) Klinikum
Munich, Germany
- Joscha Buch · Contactjoscha.buech@med.uni-muenchen.de
- Sven Peterss · Principal investigator
RecruitingCHU Bordeaux
Bordeaux, France
WithdrawnCHU de Rennes
Rennes, France
WithdrawnSemmelweis University Heart and Vascular Center
Budapest, Budapest, Hungary
CompletedAmphia Hospital (Ziekenhuis) Breda
Breda, Netherlands
Active, not recruiting
Study team
Sponsor
Vascutek Ltd.
Study ID PANTHER-001
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.